Chairman of the board

He has over 40 years’ experience in the pharmaceutical and diagnostics industry. He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche. He has been an investment advisor at HBM Partners for 12 years. He was also a board member with Illumina Inc. until 2015. Currently he is in the Board of various Life Science companies..




Paul has over 30 years of experience in the global life sciences industry, with the past 20 years of his executive career focused on Clinical Diagnostics and innovative products to improve patients’ lives. He has held leadership positions within PredictImmune, Transgenomic, ZyGEM Corp., Life Technologies (now ThermoFisher), Guava Technologies and Cellomics, raising more than $70m in funding, creating global partnerships and increasing shareholder return. Paul has spent half of his career living and working in the USA running global businesses, which gives him a novel and unique outlook on the global industry; additionally he sits on a number of Boards as non-executive director (NED) for Life Science companies.
Diadem US Inc



Member of the board

She is Founder and Managing Partner of Panakes Partners SGR one of the major Med Tech venture investors in Europe. She brings almost 20 years of experience in Venture Capital investments on a large portfolio of successful companies in Italy and Europe.
Diadem US Inc



Member of the board

He is Chairman of Circassia LtD. Francesco is Senior Advisor at Warburg Pincus. Prior, he was Executive VP at Biogen Idec, and Group VP and President for Canada and European markets at Schering-Plough Corporation. He served as Regional President for Northern Europe, Middle East and Africa at Pfizer. Currently a Board member of Italfarmaco SpA, pharmaceutical and chemical leading Italian group, Prismic Pharmaceuticals, Quanta, and a member of the strategic advisory committee at Lupin, an Indian global pharmaceutical company


Ph.D. , VP Product Development and Operations

Experienced manager with profound knowledge of life science sector. In 2009 she co-founded the company VisMederi srl and she was COO until 2016, serving clients such as Sanofi, Novartis, GSK, Takeda in vaccine immunogenicity evaluation and analytical assay validation.



Member of the board

He served as CEO of DiaSorin SpA, a multinational diagnostics company of 4.1 billion $ market cap. He led the company through growth and brings over thirty years of experience in operational, technical and business aspects in the IVD sector. Currently co-founder and Chairman of Jointherapeutics Srl, a start-up Company focused at developing innovative approaches for the management of osteoarticular pathologies.